CAR T-cell therapy is a groundbreaking, one-time therapy that uses versions of your own immune cells to find and destroy tough-to-treat blood cancers, such as multiple myeloma and leukemia.
At BMC's CAR T-cell Therapy Program, we offer the same state-of-the-art CAR T-cell therapies as larger institutions, but with a more personalized approach that takes into account all of your medical needs and life circumstances. Together, our multidisciplinary team of experts is breaking down barriers to cancer treatment and providing all the care you need throughout your journey.
Our program is led by Fabio Petrocca, MD, a world-renowned expert in CAR T-cell therapies. Along with Petrocca, providers from specialties across the hospital have joined the CAR T-cell Therapy Program because they understand the importance of providing equitable access to this life-saving treatment for all patients who may benefit from it.
Frequently Asked Questions About CAR T-cell Therapy
Istwa Arminta a
Arminta Graham rapid pou di tout moun, "Terapi CAR T se pi bon bagay ki te janm rive m '." Men, lè yo te premye ofri li tretman an, li pa te sèten li te vle li. Byento, li chanje lide li epi li te vin premye pasyan an nan BMC pou resevwa terapi sa a ki sove lavi sa a.
Maladi Nou Trete yo
Multiple Myeloma
Non-Hodgkin Lymphoma
Leukemia
Ekip Nou an
The CAR T-cell Therapy Program at BMC brings together the expertise of a wide range of specialists. Led by Dr. Fabio Petrocca, a world-renowned expert in CAR T-cell therapy, our multidisciplinary team provides coordinated care between hematology, critical care, neurology, cardiology, blood bank, laboratory medicine, social work, pharmacy, and emergency medicine.